Therapeutic efficiency of the APAF‐1 antagonist LPT99 in a rat model of cisplatin‐induced hearing loss

• Silvia Murillo‐Cuesta,
• Adelaida M Celaya,
• Blanca Cervantes,
• Jose M Bermúdez‐Muñoz,
• Lourdes Rodríguez‐de la Rosa,
• Julio Contreras,
• Isabel Sánchez‐Pérez,
• Isabel Varela‐Nieto

Affiliations

Silvia Murillo‐Cuesta

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain

Adelaida M Celaya

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain

Blanca Cervantes

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain

Jose M Bermúdez‐Muñoz

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain

Lourdes Rodríguez‐de la Rosa

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain

Julio Contreras

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain

Isabel Sánchez‐Pérez

Institute for Biomedical Research “Alberto Sols” Spanish National Research Council‐Autonomous University of Madrid Spain

Isabel Varela‐Nieto

Biomedical Research Networking Center on Rare Diseases (CIBERER) Institute of Health Carlos III Madrid Spain